Leukocyte DNA Methylation Signature Differentiates Pancreatic Cancer Patients from Healthy Controls
收藏Figshare2016-01-18 更新2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/Leukocyte_DNA_Methylation_Signature_Differentiates_Pancreatic_Cancer_Patients_from_Healthy_Controls/137988
下载链接
链接失效反馈官方服务：
资源简介：
Pancreatic adenocarcinoma (PaC) is one of most difficult tumors to treat. Much of this is attributed to the late diagnosis. To identify biomarkers for early detection, we examined DNA methylation differences in leukocyte DNA between PaC cases and controls in a two-phase study. In phase I, we measured methylation levels at 1,505 CpG sites in treatment-naïve leukocyte DNA from 132 never-smoker PaC patients and 60 never-smoker healthy controls. We found significant differences in 110 CpG sites (false discovery rate
创建时间：
2016-01-18
